MicroRNA-503 Inhibits Gastric Cancer Cell Growth and Epithelial-to-mesenchymal Transition

Overview

Journal Oncol Lett

Specialty Oncology

Date 2014 Jun 20

PMID 24944699

Citations 27

Authors

Yang Peng

Yan-Min Liu

Lu-Chun Li

Lu-Lu Wang

Xiao-Ling Wu

Affiliations

Soon will be listed here.

Abstract

Epithelial-to-mesenchymal transition (EMT) is believed to be associated with cancer cell malignancy, and also to cause cancer invasion and metastasis. Recent evidence indicates that small non-protein coding RNA [microRNAs (miRNAs/miRs)] may act as powerful regulators of EMT. The present study aimed to systematically delineate miR-503 expression in gastric cancer and analyse the function of miR-503 in gastric cancer EMT. In the present study, miR-503 expression was detected in gastric cancer cell lines and gastric cancer tissues by quantitative polymerase chain reaction. Gastric cancer cell migration, invasion and proliferation capabilities were analysed by Transwell, MTT and clonability assays. The expression of mesenchymal markers, including fibronectin, vimentin, N-cadherin, SNAIL and the epithelial marker, E-cadherin, was examined by immunoblot analysis following miR-503 transfection. miR-503 expression was found to be reduced in gastric cancer cell lines compared with normal gastric mucosa cell lines, and the expression of miR-503 was upregulated in non-metastatic-derived gastric cancer cell lines compared with metastatic-derived lines. miR-503 expression levels were significantly reduced in tumour tissues in comparison with adjacent normal mucosa tissues, and the miR-503 expression levels in patients with metastases were significantly lower than those in patients without. miR-503 inhibited gastric cancer cell migration, invasion and proliferation. Fibronectin, vimentin, N-cadherin and SNAIL protein levels were decreased, but E-cadherin expression was increased in an AGS cell line transfected with miR-503. Taken together, the present findings indicate that miR-503 acts as a novel tumour suppressor gene in gastric cancer and can inhibit EMT in gastric cancer cells.

Citing Articles

Tumor Suppressor miRNA-503 Inhibits Cell Invasion in Head and Neck Cancer through the Wnt Signaling Pathway via the WNT3A/MMP Molecular Axis.

Tang S, Fan K, You G, Huang S, Kang C, Huang Y Int J Mol Sci. 2022; 23(24).

PMID: 36555553 PMC: 9786678. DOI: 10.3390/ijms232415900.

The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.

Ferris W Front Oncol. 2022; 12:903374.

PMID: 35847932 PMC: 9277020. DOI: 10.3389/fonc.2022.903374.

SP1-Mediated Upregulation of circFAM126A Promotes Proliferation and Epithelial-Mesenchymal Transition of Oral Squamous Cell Carcinoma Regulation of RAB41.

Wang J, Ouyang S, Zhao S, Zhang X, Cheng M, Fan X Front Oncol. 2022; 12:715534.

PMID: 35237504 PMC: 8882840. DOI: 10.3389/fonc.2022.715534.

CircTMCO3 Promotes Gastric Cancer Progression by Regulating miR-577/RAB14 Axis.

Yu P, Wei K, Zhang T, Tan Z, Zhao H, Sun H Cancer Manag Res. 2021; 13:6079-6088.

PMID: 34377026 PMC: 8349533. DOI: 10.2147/CMAR.S300559.

Nuclear factor-κB inhibitor Bay11-7082 inhibits gastric cancer cell proliferation by inhibiting Gli1 expression.

Yan Y, Qian H, Cao Y, Zhu T Oncol Lett. 2021; 21(4):301.

PMID: 33732377 PMC: 7905653. DOI: 10.3892/ol.2021.12562.

References

Pillai R, Bhattacharyya S, Filipowicz W . Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol. 2007; 17(3):118-26. DOI: 10.1016/j.tcb.2006.12.007. View

Thomson J, Newman M, Parker J, Morin-Kensicki E, Wright T, Hammond S . Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006; 20(16):2202-7. PMC: 1553203. DOI: 10.1101/gad.1444406. View

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

Caporali A, Meloni M, Vollenkle C, Bonci D, Sala-Newby G, Addis R . Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation. 2011; 123(3):282-91. DOI: 10.1161/CIRCULATIONAHA.110.952325. View

Gibbons D, Lin W, Creighton C, Rizvi Z, Gregory P, Goodall G . Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 2009; 23(18):2140-51. PMC: 2751985. DOI: 10.1101/gad.1820209. View

Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y . MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol. 2012; 19 Suppl 3:S656-64. DOI: 10.1245/s10434-012-2217-6. View

Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S . Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer. 2009; 17(1):135-46. DOI: 10.1677/ERC-09-0134. View

Jiang Q, Feng M, Mo Y . Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer. 2009; 9:194. PMC: 2728105. DOI: 10.1186/1471-2407-9-194. View

Kong W, Yang H, He L, Zhao J, Coppola D, Dalton W . MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008; 28(22):6773-84. PMC: 2573297. DOI: 10.1128/MCB.00941-08. View

10.

Thiery J, Acloque H, Huang R, Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871-90. DOI: 10.1016/j.cell.2009.11.007. View

11.

Zhao X, Dou W, He L, Liang S, Tie J, Liu C . MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene. 2012; 32(11):1363-72. DOI: 10.1038/onc.2012.156. View

12.

Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

13.

Zhao J, Yang J, Lin J, Yao N, Zhu Y, Zheng J . Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2008; 25(1):13-20. DOI: 10.1007/s00381-008-0701-x. View

14.

Korpal M, Lee E, Hu G, Kang Y . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008; 283(22):14910-4. PMC: 3258899. DOI: 10.1074/jbc.C800074200. View

15.

Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q . miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem. 2011; 286(29):25992-6002. PMC: 3138315. DOI: 10.1074/jbc.M111.229401. View

16.

Gebeshuber C, Zatloukal K, Martinez J . miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009; 10(4):400-5. PMC: 2672883. DOI: 10.1038/embor.2009.9. View

17.

Zhou J, Wang W . Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. J Surg Oncol. 2011; 104(3):278-83. DOI: 10.1002/jso.21941. View

18.

Cottonham C, Kaneko S, Xu L . miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem. 2010; 285(46):35293-302. PMC: 2975153. DOI: 10.1074/jbc.M110.160069. View

19.

Watahiki A, Wang Y, Morris J, Dennis K, ODwyer H, Gleave M . MicroRNAs associated with metastatic prostate cancer. PLoS One. 2011; 6(9):e24950. PMC: 3184096. DOI: 10.1371/journal.pone.0024950. View

20.

Lu Y, Chen Y, Wang H, Tsai C, Chen W, Huang Y . Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila). 2012; 5(4):665-74. DOI: 10.1158/1940-6207.CAPR-11-0358. View